171 related articles for article (PubMed ID: 1348254)
1. Predictive testing for multiple endocrine neoplasia type 1 using DNA polymorphisms.
Larsson C; Shepherd J; Nakamura Y; Blomberg C; Weber G; Werelius B; Hayward N; Teh B; Tokino T; Seizinger B
J Clin Invest; 1992 Apr; 89(4):1344-9. PubMed ID: 1348254
[TBL] [Abstract][Full Text] [Related]
2. Practical guidelines for DNA-based testing in multiple endocrine neoplasia type 1.
Larsson C; Nordenskjold M; Skogseid B; Oberg K
Henry Ford Hosp Med J; 1992; 40(3-4):173-6. PubMed ID: 1362400
[TBL] [Abstract][Full Text] [Related]
3. Multiple endocrine neoplasia.
Larsson C; Nordenskjöld M
Cancer Surv; 1990; 9(4):703-23. PubMed ID: 1983211
[TBL] [Abstract][Full Text] [Related]
4. Screening for multiple endocrine neoplasia type 2a with DNA-polymorphism analysis.
Sobol H; Narod SA; Nakamura Y; Boneu A; Calmettes C; Chadenas D; Charpentier G; Chatal JF; Delepine N; Delisle MJ
N Engl J Med; 1989 Oct; 321(15):996-1001. PubMed ID: 2571086
[TBL] [Abstract][Full Text] [Related]
5. Haplotype analysis defines a minimal interval for the multiple endocrine neoplasia type 1 (MEN1) gene.
Debelenko LV; Emmert-Buck MR; Manickam P; Kester M; Guru SC; DiFranco EM; Olufemi SE; Agarwal S; Lubensky IA; Zhuang Z; Burns AL; Spiegel AM; Liotta LA; Collins FS; Marx SJ; Chandrasekharappa SC
Cancer Res; 1997 Mar; 57(6):1039-42. PubMed ID: 9067266
[TBL] [Abstract][Full Text] [Related]
6. Multiple endocrine neoplasia type 1 (MEN1): LOH studies in a affected family and in sporadic cases.
Valdes N; Alvarez V; Diaz-Cadorniga F; Aller J; Villazon F; Garcia I; Herrero A; Coto E
Anticancer Res; 1998; 18(4A):2685-9. PubMed ID: 9703929
[TBL] [Abstract][Full Text] [Related]
7. Screening for multiple endocrine neoplasia type 2A with DNA-polymorphism analysis.
Lamothe EM; Narod SA; Miller S; Goodfellow PJ; Cole DE; Gilchrist D; Pausova Z; Goltzman D; Hendy GN
Henry Ford Hosp Med J; 1992; 40(3-4):224-6. PubMed ID: 1362410
[TBL] [Abstract][Full Text] [Related]
8. Association of parathyroid tumors in multiple endocrine neoplasia type 1 with loss of alleles on chromosome 11.
Thakker RV; Bouloux P; Wooding C; Chotai K; Broad PM; Spurr NK; Besser GM; O'Riordan JL
N Engl J Med; 1989 Jul; 321(4):218-24. PubMed ID: 2568587
[TBL] [Abstract][Full Text] [Related]
9. Closing in on the MEN2A locus.
Simpson NE; Kidd KK
Henry Ford Hosp Med J; 1989; 37(3-4):100-5. PubMed ID: 2576936
[TBL] [Abstract][Full Text] [Related]
10. Progress toward resolving the possible linkage of multiple endocrine neoplasia type 2A to haptoglobin and group-specific loci: use of restriction fragment length polymorphisms extends exclusion region.
Kidd KK; Kidd JR; Castiglione CM; Pakstis AJ; Sparkes RS
Genet Epidemiol; 1986; 3(3):195-200. PubMed ID: 2873080
[TBL] [Abstract][Full Text] [Related]
11. Allelic deletions on chromosome 11q13 in multiple endocrine neoplasia type 1-associated and sporadic gastrinomas and pancreatic endocrine tumors.
Debelenko LV; Zhuang Z; Emmert-Buck MR; Chandrasekharappa SC; Manickam P; Guru SC; Marx SJ; Skarulis MC; Spiegel AM; Collins FS; Jensen RT; Liotta LA; Lubensky IA
Cancer Res; 1997 Jun; 57(11):2238-43. PubMed ID: 9187127
[TBL] [Abstract][Full Text] [Related]
12. One large kindred excludes a locus for multiple endocrine neoplasia type 2A from about 25% of the human autosomal genetic map.
Pakstis AJ; Kidd JR; Castiglione CM; Pletcher BA; Murphy PD; Farrer LA; Genel M; Kidd KK
Henry Ford Hosp Med J; 1987; 35(2-3):164-7. PubMed ID: 2891651
[No Abstract] [Full Text] [Related]
13. Isolation of YAC clones from the pericentromeric region of chromosome 10 and development of new genetic markers linked to the multiple endocrine neoplasia type 2A gene.
Lairmore TC; Howe JR; Dou S; Veile R; Korte-Sarfaty JA; Wells SA; Donis-Keller H
Henry Ford Hosp Med J; 1992; 40(3-4):210-4. PubMed ID: 1362407
[TBL] [Abstract][Full Text] [Related]
14. A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A.
Lichter JB; Hackleman SM; Ponder BA; Easton D; Narod SA; Lenoir GM; Gagel RF; Simpson NE; Gardner E; Goodfellow PJ
Henry Ford Hosp Med J; 1992; 40(3-4):205-9. PubMed ID: 1362406
[TBL] [Abstract][Full Text] [Related]
15. Definition of the minimal MEN1 candidate area based on a 5-Mb integrated map of proximal 11q13. The European Consortium on Men1, (GENEM 1; Groupe d'Etude des Néoplasies Endocriniennes Multiples de type 1).
Courseaux A; Grosgeorge J; Gaudray P; Pannett AA; Forbes SA; Williamson C; Bassett D; Thakker RV; Teh BT; Farnebo F; Shepherd J; Skogseid B; Larsson C; Giraud S; Zhang CX; Salandre J; Calender A
Genomics; 1996 Nov; 37(3):354-65. PubMed ID: 8938448
[TBL] [Abstract][Full Text] [Related]
16. The mapping of the locus for multiple endocrine neoplasia type 2A by linkage with chromosome 10 markers.
Simpson NE; Kidd KK
Horm Metab Res Suppl; 1989; 21():5-9. PubMed ID: 2572529
[TBL] [Abstract][Full Text] [Related]
17. Genetic testing in multiple endocrine neoplasia and related syndromes.
Calender A
Forum (Genova); 1998; 8(2):146-59. PubMed ID: 9666051
[TBL] [Abstract][Full Text] [Related]
18. Analysis of the MEN1 gene in sporadic pituitary adenomas.
Schmidt MC; Henke RT; Stangl AP; Meyer-Puttlitz B; Stoffel-Wagner B; Schramm J; von Deimling A
J Pathol; 1999 Jun; 188(2):168-73. PubMed ID: 10398160
[TBL] [Abstract][Full Text] [Related]
19. Isolation and mapping of polymorphic cosmid clones used for sublocalization of the multiple endocrine neoplasia type 1 (MEN1) locus.
Larsson C; Weber G; Kvanta E; Lewis K; Janson M; Jones C; Glaser T; Evans G; Nordenskjöld M
Hum Genet; 1992 May; 89(2):187-93. PubMed ID: 1350263
[TBL] [Abstract][Full Text] [Related]
20. [Multiple endocrine neoplasms].
Brandi ML
Recenti Prog Med; 1992 Mar; 83(3):155-9. PubMed ID: 1585036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
